1390 related articles for article (PubMed ID: 23580318)
21. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
22. Combined Retrograde/Antegrade Approach to Transcatheter Closure of an Aortic Paravalvular Leak.
Damluji AA; Kaynak HE; Heldman AW
Tex Heart Inst J; 2015 Oct; 42(5):443-7. PubMed ID: 26504437
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous paravalvular leak closure for symptomatic aortic regurgitation after CoreValve transcatheter aortic valve implantation.
Arri SS; Poliacikova P; Hildick-Smith D
Catheter Cardiovasc Interv; 2015 Mar; 85(4):657-64. PubMed ID: 25384846
[TBL] [Abstract][Full Text] [Related]
24. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
[TBL] [Abstract][Full Text] [Related]
26. Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies.
Dvir D; Barbash IM; Ben-Dor I; Torguson R; Badr S; Minha S; Pendyala LK; Loh JP; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2013; 14(3):174-81. PubMed ID: 23773501
[TBL] [Abstract][Full Text] [Related]
27. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
[TBL] [Abstract][Full Text] [Related]
28. Device closure of paravalvular defects following transcatheter aortic valve replacement with the Edwards Sapien valve.
Whisenant B; Jones K; Horton KD; Horton S
Catheter Cardiovasc Interv; 2013 Apr; 81(5):901-5. PubMed ID: 22581786
[TBL] [Abstract][Full Text] [Related]
29. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
30. Valvular performance and aortic regurgitation following transcatheter aortic valve replacement using Edwards valve versus CoreValve for severe aortic stenosis: A Meta-analysis.
Bhatheja S; Panchal HB; Barry N; Mukherjee D; Uretsky BF; Paul T
Cardiovasc Revasc Med; 2016 Jun; 17(4):248-55. PubMed ID: 26948087
[TBL] [Abstract][Full Text] [Related]
31. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
[TBL] [Abstract][Full Text] [Related]
32. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
[TBL] [Abstract][Full Text] [Related]
33. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
[TBL] [Abstract][Full Text] [Related]
34. Severe intraprosthetic regurgitation and valve embolization after transcatheter aortic valve implantation.
Ben-Dor I; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2013 Feb; 81(2):392-6. PubMed ID: 22566389
[TBL] [Abstract][Full Text] [Related]
35. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
[TBL] [Abstract][Full Text] [Related]
38. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
[TBL] [Abstract][Full Text] [Related]
39. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
Tan JS; Leipsic J; Perlman G; Stub D; Dvir D; Hansson NC; Norgaard BL; Blanke P; Cheung A; Ye J; Thompson CR; Moss RR; Lauck S; Wood D; Webb J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
[TBL] [Abstract][Full Text] [Related]
40. Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation.
Bijuklic K; Hansen L; Witt J; Schofer J
Clin Res Cardiol; 2015 Jan; 104(1):92-3. PubMed ID: 25227426
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
